# EDGAR Filing Document

**Accession Number:** 0002107788
**File Stem:** 0002107788-26-000003
**Filing Date:** 2026-6
**Character Count:** 6241
**Document Hash:** 35d559c794523b6c60db178d3174db6d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0002107788-26-000003.hdr.sgml**: 20260625

**ACCESSION NUMBER**: 0002107788-26-000003

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260625

**DATE AS OF CHANGE**: 20260625

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Aditxt, Inc.
- **CENTRAL INDEX KEY:** 0001726711
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 823204328
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-91561
- **FILM NUMBER:** 261123416

**BUSINESS ADDRESS:**
- **STREET 1:** 737 N. FIFTH STREET, SUITE 200
- **CITY:** RICHMOND
- **STATE:** VA
- **ZIP:** 23219
- **BUSINESS PHONE:** 909-488-0844

**MAIL ADDRESS:**
- **STREET 1:** 737 N. FIFTH STREET, SUITE 200
- **CITY:** RICHMOND
- **STATE:** VA
- **ZIP:** 23219

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Aditx Therapeutics, Inc.
- **DATE OF NAME CHANGE:** 20201113

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ADiTx Therapeutics, Inc.
- **DATE OF NAME CHANGE:** 20171229
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Takeover Time 2026 LLC
- **CENTRAL INDEX KEY:** 0002107788

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**BUSINESS ADDRESS:**
- **STREET 1:** SKYLINE TOWER
- **STREET 2:** 10900 NE 4TH STREET, FLOOR 23
- **CITY:** BELLEVUE
- **STATE:** WA
- **ZIP:** 98004
- **BUSINESS PHONE:** (425) 331-9885

**MAIL ADDRESS:**
- **STREET 1:** SKYLINE TOWER
- **STREET 2:** 10900 NE 4TH STREET, FLOOR 23
- **CITY:** BELLEVUE
- **STATE:** WA
- **ZIP:** 98004

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 1)**

**Aditxt, Inc.**

*(Name of Issuer)*

**Common Stock, par value $0.001 per share**

*(Title of Class of Securities)*

**—**

*(CUSIP Number)*

**Natasha Ovsepyan**<br>8403 NE 138th Street<br>Kirkland WA 98034<br>206-412-0554

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**06/23/2026**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Takeover Time 2026 LLC** | Name of reporting person<br>**Takeover Time 2026 LLC** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**WC** | Source of funds (See Instructions)<br>**WC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**0.00** | Aggregate amount beneficially owned by each reporting person<br>**0.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**0.0%** | Percent of class represented by amount in Row (11)<br>**0.0%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**OO** | Type of Reporting Person (See Instructions)<br>**OO** | |

---

**Comment for Reporting Person:** The Reporting Person disposed of all shares previously reported as beneficially owned and no longer beneficially owns any shares of Common Stock.

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Stock, par value $0.001 per share

**(b) Name of Issuer:**
Aditxt, Inc.

**(c) Address of Issuer's Principal Executive Offices:**
737 N. FIFTH STREET, SUITE 200, RICHMOND, VA, 23219

**Item 4. Purpose of Transaction**

The Reporting Person sold all shares of Common Stock previously reported as beneficially owned. The Reporting Person no longer beneficially owns any shares of Common Stock of the Issuer.

**Item 5. Interest in Securities of the Issuer**

**(a)**
The Reporting Person beneficially owns 0 shares of Common Stock, representing 0.0 percent of the outstanding Common Stock.

**(b)**
The Reporting Person has sole voting power with respect to 0 shares, shared voting power with respect to 0 shares, sole dispositive power with respect to 0 shares, and shared dispositive power with respect to 0 shares.

**(c)**
On 06/23/2026 the Reporting Person sold 3,420,439 shares of Common Stock in open market and/or brokerage transactions. Following such sale, the Reporting Person no longer beneficially owns any shares of Common Stock.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

The Reporting Person does not have any contracts, arrangements, understandings, or relationships with any person with respect to securities of the Issuer.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Takeover Time 2026 LLC

**Signature:** Natasha Ovsepyan

**Name/Title:** Managing Member / Takeover Time 2026 LLC

**Date:** 06/25/2026